Preclinical Medications Discovery and Abuse Liability Testing

The Preclinical Medications Discovery and Abuse Liability Testing contract, solicitation number 75N95021R00048, was awarded to Virginia Commonwealth University on February 22, 2022, for an amount of 973,063 dollars. Managed by the National Institutes of Health NIDA under the Department of Health and Human Services, the work is performed in Richmond, Virginia. The primary objective of this contract is to support the NIDA Addiction Treatment Discovery Program by conducting pharmacological evaluations of potential drug addiction treatment medications and preclinical abuse liability studies using rodents. These studies evaluate new street drugs, medications, and potential pharmacotherapies for drug use disorders. Additionally, the contract provides critical abuse liability data used to inform drug scheduling decisions under the Controlled Substances Act and various international treaties, including the Single Convention and Psychotropic Convention.